Ophthalmology Flashcards

(34 cards)

1
Q

What is the definition and epidemiology of cataract?

A

Cataracts is the opacification of the crystalline lens. It is estimated that50% of the world’s reversible blindness is caused by cataracts (and therefore is the leading cause of blindness worldwide).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the aetiology of cataracts?

A

Although the most common cause of cataracts is the normal ageing process (>90%), it can also be caused by trauma, metabolic disorders (diabetes mellitus), infections and glucocorticoids. <1% of cataracts are congenital, as part of a hereditary condition, or congenital conditions such as rubella

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the clinical features of cataracts?

A

The classic presentation is a gradual decrease in vision over many years. Patients are usually slow to notice, and only complain when they have significant difficulty. The patient may complain of:

  • Blurry vision (decrease in visual acuity) which is painless and bilateral
  • Glare in daylight and often when driving (by headlights). This is associated with halos around lights.
  • Washed-out colours are also a common complaint.

On examination there would be a defect in red reflex.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the diagnosis and management of cataracts

A

Cataract visible on dilated fundus examination.

Measurement of intraocular pressure is normal or may be elevated if associated with glaucoma.

The most frequent indication for cataract surgery is to improve vision. Surgery of choice globally is extracapsular cataract extraction (ECCE). Cataract surgery does no require anticoagulative measures, and complications are rare.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the types of retinal vessel occlusion?

A

Retinal vessel occlusion causes retinal ischaemia. Based on the site of occlusion, retinal vessel occlusion can be classified into the following entities:

  • Central retinal artery occlusion (CRAO)
  • Branch retinal artery occlusion (BRAO)
  • Central retinal vein occlusion (CRVO), either ischaemic (haemorrhagic retinopathy) or non-ischaemic (venous stasis retinopathy)
  • Branch retinal vein occlusion (BRVO)

Retinal vein occlusion is much more common than artery occlusion. Retinal vein occlusion is the second most common vascular disease of the retina (after diabetic retinopathy)!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the aetiology of retinal artery occlusion/amaurosis fugax?

A

Retinal artery occlusion (stroke of the eye) is either due to emboli from carotid artery atherosclerosis (most common) or atrial fibrillation, or due to thrombosis of the retinal vessels as a result of atherosclerosis. Rarer causes include vasculitis (e.g. temporal arteritis) or fibromuscular dysplasia.

  • These are also the causes of amaurosis fugax (sudden painless loss of vision followed by spontaneous recovery) which should therefore warrant investigation and treatment of the underlying cause.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the aetiology of retinal vein occlusion?

A

Retinal vein occlusion is most commonly due to systemic diseases such as atherosclerosis, hypertension and diabetes mellitus.

Central retinal vein occlusion (CRVO), either ischaemic (haemorrhagic retinopathy) or non-ischaemic (venous stasis retinopathy).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the clinical features of retinal artery occlusion?

A

General physical examination may reveal:

  • A bruit over the carotid artery is a sign of carotid atherosclerosis.
  • An irregular pulse may indicate atrial fibrillation.
  • Scalp tenderness and/or jaw claudication is a sign of temporal arteritis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the clinical features of retinal vein occlusion?

A

Branched vein occlusion is usually asymptomatic, but more common than central retinal vein occlusion.

Only ∼25% of patients with CRVO present with ischemic CRVO right at the outset. Of the rest who present with non-ischemic CRVO, a third eventually develop ischemic CRVO.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the diagnosis and investigation of retinal vessel occlusion

A

Retinal vessel occlusion is primarily a clinical diagnosis (based on thepatient’s history and fundus examination). Additional investigations are usually performed to identify underlying risk factors, to differentiate between subtypes (e.g., in the case of CRVO).

CRAO: Greyish-white discolouration of the entire retina. May also be a cherry-red spot on fovea centralis. Narrowing of all retinal vessels.

CRVO: Many dot-and-blot and/or flame haemorrhages, cotton wool spots, severe macular oedema and papilloaedema.

For retinal artery occlusion, evaluation for cardiovascular risk factors:

  • Carotid doppler (to look for atherosclerotic plaques)
  • Echocardiography (to look for potential sources of emboli)
  • Tests to rule out temporal arteritis: ESR, temporal artery biopsy

Retinal vein occlusion: Fluorescein angiography: in order to differentiate ischemic from non-ischemic forms of retinal vein occlusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the management of retinal artery occlusion?

A

Retinal artery occlusion is an ophthalmologic emergency. Treatment should be initiated ASAP, as permanent damage occurs within 1.5 hours of CRAO. Treatment options include:

  • Eyeball massage
  • Carbogen therapy: inhaling a mixture of 5% CO2 and 95% O2
  • Decrease intraocular pressure with drugs and/or surgical therapy (e.g., paracentesis of the anterior chamber)
  • Vasodilators (e.g., calcium channel blockers, sublingual nitroglycerine)
  • High-dose glucocorticoid therapy if temporal arteritis is suspected
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the management of retinal vein occlusion?

A

Ischemic CRVO must be treated with:

  • Laser therapy
    • Panretinal photocoagulation
    • If macular oedema is present: grid photocoagulation
  • Intravitreal injection of VEGF inhibitors and/or steroids to prevent neovascularisation of the retina or iris.

BRVO and non-ischemic CRVO usually do not require treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the potential complications of CRVO (Central Retinal Vein Occlusion)?

A

Ischaemic CRVO is most commonly associated with neovascularisation due to release of VEGF.

  • Neovascularization of the iris (rubeosis iridis) → neovascular glaucoma
  • Neovascularization of the retina → vitreous haemorrhage → retinal detachment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the definition and epidemiology of Glaucoma?

A

Glaucoma is a group of eye-diseases that result in damage to the optic nerve and visual loss. Usually caused by an increase in intra-ocular pressure.

Glaucoma is the second leading cause of blindness in the world, causing permanent vision loss.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the aetiology of and risk factors for Open-Angle Glaucoma?

A

Open-angle glaucoma is caused by slowed drainage of the trabecular meshwork, but an anatomically open angle. It is the most common cause of glaucoma, affecting 2/3 of patients.

Risk factors for POAG (primary open-angle glaucoma) include:

  • Age - is present in around 2% of people older than 40 years.
  • Genetics: first degree relatives of an open-angle glaucoma patient have a 16% chance of developing the disease
  • Black patients
  • Myopia (short-sightedness) as opposed to hypermetropia which is associated with closed-angle glaucoma.
  • Hypertension
  • Diabetes mellitus
  • Corticosteroids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the clinical features of Open-Angle Glaucoma?

A

Patients often have a diagnosis of intra-ocular pressure (50%).

Patients rarely experience symptoms, rather discovered during comprehensive ophthalmic examination. This is in contrast to closed-angle glaucoma which has many symptoms and signs.

On Examination

  • Peripheral vision loss in advanced disease, shown by missing areas in the field of vision.
  • Scotomas also found on visual field testing.
  • Cupping of the optic disk (increased cup:disk ratio of >0.7).
  • Retinal haemorrhages are uncommon
17
Q

What are the investigations for Open-Angle Glaucoma?

A

Tonometry shows elevated intra-ocular pressure above the normal range (>21mmHg).

Ophthalmoscopy shows cup-to-disk ratio over 0.7. Asymmetry of greater than 0.2 between the two is also a sign of glaucoma.

Visual field testing should be done in all patients.

18
Q

Describe the management of Open-Angle Glaucoma

A

Management of ocular hypertension (OH), suspected primary open angle glaucoma (POAG), and confirmed POAG are normally under the direction of an ophthalmologist. The aim is to prevent progression of visual field loss.

  • First-line treatment includes topical prostaglandin analogues such as latanoprost. Adverse effects include brown pigmentation of the iris, increased eyelash length. Alternative second-line options include:
  • Beta-blockers (e.g. timolol, betaxolol) reduces aqueous humour production but should be avoided in asthmatics and patients with heart block.
  • Sympathomimetics such as brimonidine reduce aqueous production and increase outflow.
  • Carbonic anhydrase inhibitor reduce aqueous production.

Surgery in the form of a trabeculectomy may be considered in refractory cases.

19
Q

What are the clinical features of Closed-Angle Glaucoma?

A

Acute

Patients present with an acute onset headache, with aching eye or brow pain and nausea/vomiting.

Also complain of reduced visual acuity, blurred vision and halos around lights and eye redness.

Chronic

Most patients are asymptomatic, and usually found on ophthalmic examination.

20
Q

Describe the management of Closed-Angle Glaucoma

A

If acute angle closure is suspected, admit immediately for specialist ophthalmology assessment and treatment.

Let the person lie flat with their face up and head not supported by pillows, as this may relieve some of the pressure on the angle. If the drugs are available, give:

  • Pilocarpine (muscarinic receptor agonist causing miosis and allowing drainage of aqueous humour) eye drops, one drop of 2% in blue eyes or 4% in brown eyes;
  • Acetazolamide 500 mg orally to reduce production of aqueous humour (provided that there are no contraindications)
  • Analgesia
  • Anti-emetic if required.
21
Q

What is the definition and aetiology of Anterior Uveitis?

A

Anterior uveitis is one of the important differentials of a red eye. It is also referred to as iritis. Anterior uveitis describes inflammation of the anterior portion of the uvea - iris and ciliary body. It is associated with HLA-B27 and may be seen in association with other HLA-B27 linked conditions (see below).

Associated conditions

  • Ankylosing spondylitis
  • Reactive arthritis
  • Ulcerative colitis, Crohn’s disease
  • Behcet’s disease
  • Sarcoidosis: bilateral disease may be seen
22
Q

What are the clinical features of Anterior Uveitis?

A

Anterior uveitis is a cause of red eye and is usually of acute onset but presents with progressive ocular discomfort & pain (may increase with use). Patients also complain of:

  • Photophobia (often intense)
  • Blurred vision

On examination, pupil may be irregular and small, there may be lacrimation and ciliary flush. Hypopyon; describes pus and inflammatory cells in the anterior chamber, often resulting in a visible fluid level.

23
Q

What are the investigations for Anterior Uveitis?

A

Slit lamp examination shows:

  • Leukocytes in the anterior chamber
  • Protein in the aqueous humour → vitreous haze
  • Signs of inflammation of the iris (e.g., red eye, hypopyon).

Conjunctival smear and cytology if infectious cause is suspected.

Tonometry to exclude secondary open-angle glaucoma. Cells in the anterior chamber may cause impaired drainage of aqueous humour.

24
Q

Describe the management of Anterior Uveitis

A

Urgent review by ophthalmology.

Cycloplegics (dilates the pupil which helps to relieve pain and photophobia) e.g. Atropine, cyclopentolate

Steroid eye drops

25
What is the definition and epidemiology of the different types of Age-related Macular Degeneration?
Age-related macular degeneration (AMD) is a degenerative disease of the retina and represents the **most common cause of blindness in individuals \> 65 years** in developed countries. It is classified into two major forms: dry AMD and wet AMD. * **Dry AMD (90%)** is caused by **deposition of various metabolites** under the retinal pigment epithelium (drusen) and usually **develops over decades** * **Wet AMD (10%)** is caused by **neovascularisations growing into the subretinal space** and manifests within **weeks to months or even acutely**. Both forms ultimately cause impaired central vision and can, in rare cases, lead to complete blindness.
26
What is the aetiology of Age-related Macular Degeneration?
AMD is ultimately caused by various molecular consequences of ageing. Risk factors include: * **Advanced age** * **Family history** and genetic predisposition - First degree relatives of a sufferer of ARMD are thought to be four times more likely to inherit the condition. * **Smoking** * Cardiovascular disease * Obesity
27
What are the clinical features of Age-related Macular Degeneration?
Dry AMD: **slow progressive visual impairment** (usually over decades) and **unilateral or bilateral onset.** Wet AMD: **acute or insidious onset** (over weeks to months) and **usually manifests in one eye first** * ***Painless* central or pericentral visual impairment** → * **Reduced visual acuity.** This section of the visual field is needed to perform tasks like reading. Patients therefore often notice the impairment first when they have **difficulty reading**. The severity of symptoms can change from day to day. * Difficulty adapting to changes in lighting with an overall **deterioration in vision at night**. * **Metamorphopsia**: type of visual distortion in which **straight lines appear wavy**, which can be tested for using an Amsler grid. * **Scotoma** (blind spot) is a late sign in dry AMD, but an early sign in wet AMD.
28
Describe the diagnosis of Age-related Macular Degeneration
29
Describe the management of Age-related Macular Degeneration
Supportive treatment is important in AMD, as the not much is available for dry AMD: * **Patient education -** e.g. **instructions on self-monitoring using the Amsler grid**. * **Visual and reading aids**: magnifying glass * **Avoid risk factors** (e.g., cessation of smoking) * **Improve diet** (i.e., high in green leafy vegetables and fish) *Dry AMD* The AREDS trial examined the treatment of dry ARMD in 3640 subjects. It showed that a combination of **zinc with anti-oxidant vitamins A,C and E reduced progression of the disease** by around one third. Patients with more extensive drusen seemed to benefit most from the intervention. Treatment is therefore recommended in patients with at least **moderate category dry ARMD**. *Wet AMD* * A number of trials have shown that use of **anti-VEGF agents** can limit progression of wet ARMD and stabilise or reverse visual loss. Evidence suggests that they should be instituted within the **first two months of diagnosis of wet ARMD if possible**. Examples of anti-VEGF agents include **ranibizumab**, bevacizumab and pegaptanib,. The agents are usually administered by 4 weekly injection. * **Laser photocoagulation** does slow progression of ARMD where there is new vessel formation, although there is a **risk of acute visual loss after treatment**, which may be increased in patients with sub-foveal ARMD. For this reason anti-VEGF therapies are usually preferred.
30
What is the definition and epidemiology of Posterior Vitreous Detachment?
Posterior vitreous detachment is the **separation of the vitreous membrane from the retina**. This occurs due to natural changes to the vitreous fluid of the eye with ageing. * Posterior vitreous detachment is a **common condition** that does not cause any pain or loss of vision. Occurring in **over 75% of people over the age of 65**. * However, rarely the separation of the vitreous membrane can lead to tears and detachment of the retina. It is important to rule out retinal tears or retinal detachment in anyone with suspected posterior vitreous detachment, as they may result in permanent loss of vision.
31
What are the risk factors for Posterior Vitreous Detachment?
Risk factors: * **Age:** As people age, the vitreous fluid in the eye becomes less viscous, and thus, does not hold its shape as well. Therefore, it pulls the vitreous membrane away from the retina towards the centre of the eye. * **Myopia:** Highly myopic (near-sighted) patients are also at increased risk of developing posterior vitreous detachment earlier in life. This is because the myopic eye has a longer axial length than an emmetropic eye.
32
What are the clinical features of Posterior Vitreous Detachment?
Patients present with the **sudden appearance of floaters** (occasionally a ring of floaters temporal to central vision) accompanied by **flashes of light in vision**. They may also have **blurred vision.** The appearance of a **dark curtain** descending down vision means that there is also **retinal detachment**.
33
What are the investigations for Posterior Vitreous Detachment?
34
Describe the management of Posterior Vitreous Detachment
Posterior vitreous detachment alone does not cause any permanent loss of vision. **Symptoms gradually improve** over a period of around 6 months and therefore **no treatment is necessary**. If there is an associated retinal tear or detachment the patient will require surgery to fix this.